Digital Health Investment Weekly Report [Issue 160]

Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!

01 Global Digital Health Investment and Financing Overview

Health Insurance Consulting Service Provider Chapter Raises $75 Million in Series D Funding

April 16,Chapter, a Medicare consulting service provider for seniors, has raised $75 million in Series D funding led by Stripes, with participation from XYZ Venture Capital, Susa Ventures, Addition, Narya Capital, and Maverick Ventures. The funding will be used to deepen its enterprise partnerships, invest in new data and technology infrastructure to provide smarter and more proactive member recommendations, and accelerate Chapter's impact on senior citizens across the United States.

Virtual Healthcare Delivery Platform hellocare.ai Secures $47 Million Growth Funding Round

On April 15, virtual healthcare delivery platform hellocare.ai secured a $47 million growth funding round led by HealthQuest Capital, with participation from Bon Secours Mercy Health, UCHealth, OSF Ventures, and LRVHealth. The funds will be used to further expand its AI-assisted virtual care solutions, support its rapid expansion in the U.S. and globally, enhance platform functionalities, better integrate with existing healthcare systems, and drive the development of next-generation healthcare.

Genetic and Assisted Reproductive Medical Service Provider Winsota Healthcare Secures $35 Million in Strategic Financing

On April 9, Yunchengda Medical, a provider of genetic and assisted reproductive medical services, secured $35 million in strategic funding. The proceeds will primarily be used for new technology research and development, intelligent upgrades, further refinement of a precision service system, and expansion of its global assisted reproductive services network.

Noliving Biotech, a developer of new high-end medical devices, secures hundreds of millions of RMB in Series C financing

On April 15, Noliving Biotech, an innovative high-end medical device developer, secured hundreds of millions of RMB in its Series C financing round, led by Trust Capital with participation from Yangzhou Guojin Group, Zhongshan Financial Control, and several other well-known institutions. The funds will be used to expand production capacity, commercialize, and facilitate the overseas layout of the company’s first key product, a "portable NO inhalation therapy device," while accelerating the ongoing development of subsequent innovations based on NO sustained-release and generation technologies.

Shenzhen Shinesky Biotechnology Co., Ltd., a Supramolecular Science and Technology R&D Company, Secures Nearly RMB 100 Million in Series C Financing

On April 16, Shenzhen Shinesky Biotechnology Co., Ltd., a supramolecular science and technology R&D company, secured nearly RMB 100 million in its Series C financing round led by OrbiMed China. The funds will be used for upgrading its AI R&D platform, expanding new material applications, and developing new energy businesses.

iRegene, Focusing on the iPSC Chemical Induction Platform, Secures Nearly RMB 100 Million in B+ Round Financing

On April 11, iRegene, which focuses on the iPSC chemical induction platform, secured nearly RMB 100 million in a B+ round of financing led by Fengchuan Capital, with participation from Hotang Ventures. The proceeds will be used to accelerate the industrialization and commercialization of the company's various pipelines and further advance the development of its world-leading small-molecule chemical transcriptional regulation iPSC technology platform to meet unmet clinical needs.

Neurotechnology Solutions Developer Phantom Neuro Secures $19 Million in Series A Funding

On April 15, Phantom Neuro, a developer of neurotechnology solutions, secured $19 million in Series A funding led by Ottobock, with participation from existing investors such as Breakout Venture and new investors including Actual VC. The funds will be used to accelerate the clinical trials and commercialization process of Phantom X, support preclinical testing, completion of first-in-human trials, regulatory submissions, and expand R&D efforts for broader control applications beyond prosthetics.

AI Beauty Platform Bliss Aesthetics Secures $17.5 Million in Seed Funding

On April 10, artificial intelligence beauty platform Bliss Aesthetics secured $17.5 million in seed funding, led by Shine Capital, with participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners. The funds will be used to launch an AI platform connecting patients with certified plastic surgeons.

Fertility Care Services Provider Cofertility Completes $16 Million Series A Financing

On April 16, fertility care service provider Cofertility completed a $16 million Series A financing round, led by Next Ventures and Offline Ventures, with participation from Initialized Capital, Arkitekt Ventures, Foreground Capital, and others. The funds will be used to support expansion and increase projects and services to meet the growing demand in the fertility industry.

Magnetic Sensor Medical Device Developer Neuranics Secures $8 Million in Seed Funding

On April 10, Neuranics, a developer of magnetic sensor medical devices, secured $8 million in seed funding led by Blackfinch Ventures with participation from Archangels. The University of Glasgow, Par Equity, and Old College Capital, the venture capital fund of the University of Edinburgh, continued their support. The funds will be used to accelerate the development and commercial application of Tunnel MagnetoResistance (TMR) magnetic sensing technology.

Healthera, a Personal Health Management Solutions Provider, Secures £2 Million in Strategic Funding

On April 16, Healthera, a personal health management solutions provider, secured £2 million in strategic funding to accelerate the growth of its digital pharmacy platform and expand into North America.

Philips Signs Memorandum of Cooperation with WanSi Medical to Empower China's Medical Market

On April 15, Philips Healthcare and WanSi Medical signed a Memorandum of Cooperation to deepen collaboration on intelligent diagnosis and treatment in vascular intervention. Through technical synergy and resource sharing, both parties will provide comprehensive human-machine intelligent solutions, aiming to promote the innovative development of China's medical market. This cooperation focuses on intelligent solutions in the field of vascular intervention, combining Philips' advanced technology with WanSi Medical's localized capabilities, committed to enhancing the overall level of China's medical market.

Nextech and Ocuco Reach AgreementStrategic Cooperation to Create an Integrated End-to-End Ophthalmic Care Platform

On April 14, Nextech and Ocuco reached a strategic partnership aimed at creating a fully integrated end-to-end ophthalmic care platform that combines clinical care with optical retail performance. The two parties will integrate Ocuco's optical software solution, Acuitas 3, with Nextech's ophthalmology platform, aiming to create a seamless workflow for eye care professionals and their patients while equipping clinics with the necessary tools to manage both the clinical and retail aspects of care. This collaboration will enhance operational efficiency, improve patient experience, and better integrate clinical and retail operations for ophthalmology and optometry clinics.

Mabwell Biotherapeutics and Deep Potential Technology Reach Strategic Cooperation to Build a New Paradigm for AI-Driven Innovative Drug R&D

On April 14, Mabwell Biotherapeutics and Deep Potential Technology announced a strategic partnership to combine the strengths of biopharmaceutical R&D with large AI models, jointly building a large model platform for biopharmaceutical research and development. The collaboration focuses on constructing a knowledge engine and exploring innovative targets, aiming to shift biopharmaceutical R&D from experiment-driven to computation-driven, enhancing R&D efficiency and meeting global clinical needs.

Kossel Medical Collaborates with the First Affiliated Hospital of Wenzhou Medical University and Vascular Cube to Drive New Breakthroughs in Cardiac Pacing Techniques

On April 11, Kexier Medical collaborated with the First Affiliated Hospital of Wenzhou Medical University and the Vascular Cube Device Incubation Platform on the Cathlink® Lead Delivery Sheath Set (referred to as the "K-sheath"). The collaboration focuses on synergistic clinically-driven partnerships, innovative technology transfer cooperation, and platform-based product development cooperation. Chinese physicians, leveraging clinical practice, invent procedural methods that facilitate the rapid transformation of research outcomes; local innovative enterprises actively promote the implementation of collaborations to achieve swift commercialization of results.

Non-Profit Healthcare Provider Cone Health Acquires HealthTeam Advantage

On April 16, nonprofit healthcare provider Cone Health purchased the remaining ownership of HealthTeam Advantage from Novant Health, becoming the sole owner of this Medicare Advantage payer. HealthTeam Advantage has 22,000 members across six MA plans in North Carolina. Through this acquisition, Cone Health has further invested in a project with high profit potential but significant turbulence in recent years, primarily due to soaring costs for Medicare seniors exceeding reimbursement levels and regulators attempting to curb practices such as overcoding.

Artery Network/Artery Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.

Compiled by: Hou Zhancan, Huang Changjian‍‍‍

Share

Like

Tap to view